The use of leukaemia Q-fusion gene screening assay (Q30) in the diagnostic evaluation of acute myeloid leukaemia (AML).

Tayabali, Sarrah; Baker, Robert; Nacheva, Elisabeth; O'Nions, Jenny; Gupta, Rajeev; Wilson, Andrew J; Xu, Ke

Tayabali, Sarrah; Baker, Robert; Nacheva, Elisabeth; O'Nions, Jenny; Gupta, Rajeev; Wilson, Andrew J; Xu, Ke.

Afiliação

Tayabali S; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, 250 Euston Road, London, NW1 2PG, UK.
Baker R; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, 250 Euston Road, London, NW1 2PG, UK.
Nacheva E; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK.
O'Nions J; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, 250 Euston Road, London, NW1 2PG, UK.
Gupta R; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK.
Wilson AJ; UCL School of Life and Medical Sciences, London, UK.
Xu K; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, 250 Euston Road, London, NW1 2PG, UK.

J Hematop ; 17(1): 37-39, 2024 Mar.

Article em En | MEDLINE | ID: mdl-38376723

Assuntos

Leucemia Mieloide Aguda; Humanos; Leucemia Mieloide Aguda/diagnóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google